Camber Pharma Launches Generic Abilify®
Piscataway, NJ, April 20, 2015– Camber Pharmaceuticals announces that it has launched Aripiprazole 2,5,10,15,20 and 30 tablets. The drug is the generic version of Abilify® tablets. Aripiprazole is used to treat schizophrenia, bipolar disorder and depression.
Aripiprazole is available in 30ct bottles.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class






